Nevertheless, Spiller and colleagues suggested that, in TDP-43 pathology (using rNLS8 mutation), it might be more efficient to find ways of how to encourage appropriate microglia-mediated inflammation, to clear pathological TDP-43 proteins and help axonal regeneration during the onset/progress of ALS [190]. The gene discussed is TARDBP; the disease is amyotrophic lateral sclerosis.